• Skip to main content

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login

News

News

z3admin / August 26, 2015

Aug 26, 2015 / Halo Pharmaceutical

Halo Pharmaceutical Makes Key Additions to Management Team

Whippany, New Jersey, August 26, 2015 – Halo Pharmaceutical, a rapidly growing Contract Development and Manufacturing Organization (CDMO), is pleased to …

➞

z3admin / August 3, 2015

Aug 03, 2015 / IBA Molecular

Illinois Health and Science Completes Acquisition of IBA Molecular North America

August 3, 2015 – IBA Molecular, a global leader in the manufacture and distribution of radiopharmaceuticals, announced today the completion of the previously …

➞

z3admin / July 2, 2015

Jul 02, 2015 / Archroma

Archroma Successfully Completes USD 515 Million Credit Facilities Offering

Senior secured term loans and revolving credit facility of approximately USD 515 million. Loans to be used to refinance Archroma's existing debt and …

➞

z3admin / July 1, 2015

Jul 01, 2015 / Archroma

Archroma Completes Acquisition of BASF Textile Chemicals Business

REINACH, July 1, 2015 - Archroma, a global leader in specialty chemicals for the textile, paper and emulsions sectors, announced today that it has closed the …

➞

z3admin / April 30, 2015

Apr 30, 2015 / AEB Group

SK Capital Closes Control Investment In AEB Group

Represents the Seventh Portfolio Company in SK Capital’s Fund III Brescia, Italy - April 30, 2015 — SK Capital Partners, a private investment firm with a …

➞

z3admin / April 17, 2015

Apr 17, 2015 / IBA Molecular

Health Care System To Acquire IBA Molecular North America

Dulles, VA, April 17, 2015 - IBA Molecular, a global leader in the manufacture and distribution of radiopharmaceuticals, announced today that it has signed a …

➞

  • ➞
  • Go to page 1
  • Interim pages omitted …
  • Go to page 18
  • Go to page 19
  • Go to page 20
  • Go to page 21
  • Go to page 22
  • Interim pages omitted …
  • Go to page 25
  • ➞

© 2023 SK Capital Partners. All Rights Reserved.

Important Disclosures

  • Home
  • About
    • Overview
    • Owners and Intermediaries
    • Management Teams
    • Investors
    • Back
  • Strategy
    • Overview
    • Disciplined Sector Focus
    • Long-Term Business Improvement
    • Investment Criteria & Transaction Profile
    • Back
  • Sustainability
    • ESG Principles
    • Implementation
    • Core Areas
    • SK Portfolio EcoVadis Ratings
    • SKCP ESG Report
    • Back
  • Portfolio
  • Team
  • News
  • Contact
  • Investor Login